Mutant p53 gain-of-function induces epithelial-mesenchymal transition through modulation of the miR-130b-ZEB1 axis.
about
The overexpression of MCPH1 inhibits cell growth through regulating cell cycle-related proteins and activating cytochrome c-caspase 3 signaling in cervical cancerThe expanding regulatory universe of p53 in gastrointestinal cancerThe Role of microRNAs in the Diagnosis and Treatment of Pancreatic AdenocarcinomaBiomarkers and Targeted Therapy in Pancreatic CancerDysregulation of microRNA biogenesis in cancer: the impact of mutant p53 on Drosha complex activityClinical Overview of MDM2/X-Targeted TherapiesRegulation of Mutant p53 Protein ExpressionMicroRNA Regulation of Epithelial to Mesenchymal TransitionMiRNAs and Other Epigenetic Changes as Biomarkers in Triple Negative Breast CancerEMT-Inducing Molecular Factors in Gynecological CancersReactivating p53 functions by suppressing its novel inhibitor iASPP: a potential therapeutic opportunity in p53 wild-type tumorsThe Emerging Role of miRNAs in HTLV-1 Infection and ATLL PathogenesisEmerging therapeutic biomarkers in endometrial cancerTranscriptional control of cancer metastasisTumor suppressor p53 and its gain-of-function mutants in cancerMutant p53 regulates ovarian cancer transformed phenotypes through autocrine matrix deposition.Emerging Non-Canonical Functions and Regulation by p53: p53 and StemnessΔNp63α and microRNAs: leveraging the epithelial-mesenchymal transitionMore targets, more pathways and more clues for mutant p53.Role of microRNA in epithelial to mesenchymal transition and metastasis and clinical perspectives.miR-600 inhibits cell proliferation, migration and invasion by targeting p53 in mutant p53-expressing human colorectal cancer cell lines.Involvement of DNA damage response pathways in hepatocellular carcinoma.ZEB1 sensitizes lung adenocarcinoma to metastasis suppression by PI3K antagonism.Epigenetic regulation of epithelial-mesenchymal transitionEpithelial-to-Mesenchymal Transition in the Female Reproductive Tract: From Normal Functioning to Disease Pathology.High expression of microRNA-130b correlates with poor prognosis of patients with hepatocellular carcinomaThe impact of microRNA-mediated PI3K/AKT signaling on epithelial-mesenchymal transition and cancer stemness in endometrial cancer.MicroRNA-101 targets EZH2, MCL-1 and FOS to suppress proliferation, invasion and stem cell-like phenotype of aggressive endometrial cancer cellsMicroRNA-130b promotes cell aggressiveness by inhibiting peroxisome proliferator-activated receptor gamma in human hepatocellular carcinoma.Mutant p53 attenuates the anti-tumorigenic activity of fibroblasts-secreted interferon betamicroRNAs: short non-coding bullets of gain of function mutant p53 proteins.MiR-130b is a prognostic marker and inhibits cell proliferation and invasion in pancreatic cancer through targeting STAT3Cadherin 6 is a new RUNX2 target in TGF-β signalling pathwayMutant p53 cooperates with knockdown of endogenous wild-type p53 to disrupt tubulogenesis in Madin-Darby canine kidney cells.A mutant p53/let-7i-axis-regulated gene network drives cell migration, invasion and metastasis.Clinical implications of miRNAs in the pathogenesis, diagnosis and therapy of pancreatic cancer.RETRACTED: Up-regulation of miR-130b expression level and down-regulation of miR-218 serve as potential biomarker in the early detection of human osteosarcomaSUMOylation at K707 of DGCR8 controls direct function of primary microRNA.MicroRNA-532 and microRNA-3064 inhibit cell proliferation and invasion by acting as direct regulators of human telomerase reverse transcriptase in ovarian cancer.SUMOylation of TARBP2 regulates miRNA/siRNA efficiency.
P2860
Q24339317-1B57EC5D-D757-4918-8C05-68A81F8E8D40Q26742058-E438DE93-4128-4F22-A276-8780927BA252Q26744298-569543EB-C606-4A8E-882E-D7C20B245ECFQ26752755-3F0A2D34-6BA2-4192-875E-1F6F75CA466AQ26766173-0833AB7D-A6B8-411F-BA6F-12F086C229B1Q26767402-D9D5D7FD-FC03-43FA-9443-E7A6BF418C0CQ26770579-3B25745B-4607-419E-92DA-30C0B75E2200Q26771110-2AD4CBF9-27B1-4385-B3E8-D5A8D91860B3Q26775086-80B80848-48A4-499B-941F-BA5C782A7907Q26781912-B7790242-D326-4A52-B701-21BDFD6903FCQ26783710-C55A2858-FC3B-4D80-B0D4-A052776E0584Q26800055-1ED0B8C8-E41C-4AB9-9C81-1417426E55F8Q26865904-C2BDAEDA-3663-488E-8F78-D1CE373D5722Q26992024-35BC641D-EC30-48AA-A87E-251B45C03845Q27000754-58933F05-7B3E-4B44-8789-937CED96A9DAQ27333756-13D66854-9AB6-4B07-A712-0DAAFAEDFC87Q28077156-135C880B-DF4D-46B3-8503-438561BE3284Q28077508-70EE396B-E80D-4551-9016-D1C65BB5EDEDQ30542607-B4B46449-0175-4BEF-9EC2-EFCFBBC4CCFAQ33559304-EFAB6A00-FD3B-40E8-8B45-DA1BAE4A6C0BQ33599315-7F2476DB-FF68-4375-B792-3AC1A4DA71E2Q33616812-0E4BE618-8250-497A-94BD-8E64EDBA7091Q33685931-D1CBCF47-F016-42C2-BF31-BD1A70AA94DAQ33764436-2298002E-05D5-48DC-ABFE-5BC8543283C5Q33872622-C7EED335-CA59-4809-8E8C-8DE686BE95A3Q34079131-91D53DA2-C8A0-426B-BF7B-D68CEB4237AAQ34091442-7E846134-A58C-43AE-B267-C41FDF6774FCQ34227586-E4EF23C6-2DB2-4180-A4B6-EB4BBE8ED973Q34685429-C5EF77B5-6448-40B8-A211-E42DBF67E524Q34695472-55C647F9-2E13-4255-81AE-8B91B22619BFQ34832663-61FC47CD-9C6B-4775-B445-43AF847B8065Q34989346-92CD1DF2-7565-42A3-BB3E-B9F70B1D9672Q34999638-0C5E873D-F998-46C6-BF08-8C6460CD936EQ35081210-FBBE61BF-E37B-4C58-A9F6-EA8F9DD4D838Q35339915-CB60199F-A9FD-41F6-99EB-E331C1D12B1CQ35735278-834137F7-1682-4AEE-9462-DAD0B9DF78F4Q36131618-5FDED607-138A-49BC-9D23-687B658000CCQ36299161-C9CA2DB0-F38E-4C96-B340-4CDC7182098BQ36307498-87B7AA02-9965-47EC-920C-9CD938E8418DQ36358151-C9EE894D-940E-49FE-B8B5-59BCAAA17057
P2860
Mutant p53 gain-of-function induces epithelial-mesenchymal transition through modulation of the miR-130b-ZEB1 axis.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Mutant p53 gain-of-function in ...... ion of the miR-130b-ZEB1 axis.
@en
type
label
Mutant p53 gain-of-function in ...... ion of the miR-130b-ZEB1 axis.
@en
prefLabel
Mutant p53 gain-of-function in ...... ion of the miR-130b-ZEB1 axis.
@en
P2093
P2860
P50
P356
P1433
P1476
Mutant p53 gain-of-function in ...... tion of the miR-130b-ZEB1 axis
@en
P2093
P2860
P2888
P304
P356
10.1038/ONC.2012.334
P407
P577
2012-07-30T00:00:00Z